FI961900A - Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä - Google Patents

Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä Download PDF

Info

Publication number
FI961900A
FI961900A FI961900A FI961900A FI961900A FI 961900 A FI961900 A FI 961900A FI 961900 A FI961900 A FI 961900A FI 961900 A FI961900 A FI 961900A FI 961900 A FI961900 A FI 961900A
Authority
FI
Finland
Prior art keywords
factor viii
containing fraction
preparation
chromatographic procedures
virus inactivated
Prior art date
Application number
FI961900A
Other languages
English (en)
Swedish (sv)
Other versions
FI116569B (fi
FI961900A0 (fi
Inventor
Ales Strancar
Monika Andrea Stadler
Djuro Josic
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6501733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI961900(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI961900A publication Critical patent/FI961900A/fi
Publication of FI961900A0 publication Critical patent/FI961900A0/fi
Application granted granted Critical
Publication of FI116569B publication Critical patent/FI116569B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI961900A 1993-11-04 1996-05-03 Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä FI116569B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4337573 1993-11-04
DE4337573A DE4337573C1 (de) 1993-11-04 1993-11-04 Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden
EP9403258 1994-09-30
PCT/EP1994/003258 WO1995012609A1 (de) 1993-11-04 1994-09-30 Verfahren zur herstellung einer virusinaktivierten faktor viii enthaltenden fraktion mittels chromatographischer methoden

Publications (3)

Publication Number Publication Date
FI961900A true FI961900A (fi) 1996-05-03
FI961900A0 FI961900A0 (fi) 1996-05-03
FI116569B FI116569B (fi) 2005-12-30

Family

ID=6501733

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961900A FI116569B (fi) 1993-11-04 1996-05-03 Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä

Country Status (21)

Country Link
EP (1) EP0726907B1 (fi)
JP (1) JP3739788B2 (fi)
KR (1) KR960705841A (fi)
CN (1) CN1109045C (fi)
AT (1) ATE228533T1 (fi)
AU (1) AU687451B2 (fi)
CA (1) CA2175670C (fi)
CZ (1) CZ290186B6 (fi)
DE (2) DE4337573C1 (fi)
ES (1) ES2182846T3 (fi)
FI (1) FI116569B (fi)
HU (1) HU222087B1 (fi)
IL (1) IL111263A (fi)
MY (1) MY113294A (fi)
NO (1) NO317112B1 (fi)
PL (1) PL181725B1 (fi)
RU (1) RU2148411C1 (fi)
SK (1) SK284215B6 (fi)
UA (1) UA43855C2 (fi)
WO (1) WO1995012609A1 (fi)
ZA (1) ZA948667B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618851C1 (de) * 1996-05-10 1997-07-24 Octapharma Ag Verfahren zur Eignungsprüfung von Faktor VIII-haltigen Proteinfraktionen
WO1997033178A1 (de) * 1996-03-08 1997-09-12 Octapharma Ag Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
ES2137878B1 (es) * 1997-12-01 2000-10-01 Grifols Grupo Sa Procedimiento de obtencion de un plasma humano atenuado de virus para uso terapeutico.
RU2567811C2 (ru) * 2008-06-24 2015-11-10 Октафарма Аг Способ очистки фактора свертывания крови viii
CA2821711C (en) 2010-12-15 2017-10-10 Baxter International Inc. Eluate collection using conductivity gradient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
JPS62191042A (ja) * 1986-02-17 1987-08-21 Kanegafuchi Chem Ind Co Ltd 血液凝固第８因子吸着体およびそれを用いた血液凝固第８因子の精製法
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
CA2001720C (en) * 1988-10-31 2001-10-02 Randal A. Goffe Membrane affinity apparatus and purification methods related thereto
DE3878245D1 (de) * 1988-11-05 1993-03-18 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
CH678155A5 (fi) * 1989-08-09 1991-08-15 Fischer Ag Georg
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation

Also Published As

Publication number Publication date
IL111263A0 (en) 1994-12-29
CA2175670A1 (en) 1995-05-11
HUT76530A (en) 1997-09-29
MY113294A (en) 2002-01-31
CZ118796A3 (en) 1996-12-11
UA43855C2 (uk) 2002-01-15
AU687451B2 (en) 1998-02-26
SK284215B6 (sk) 2004-11-03
PL181725B1 (pl) 2001-09-28
ATE228533T1 (de) 2002-12-15
JP3739788B2 (ja) 2006-01-25
JPH09504532A (ja) 1997-05-06
NO961816D0 (no) 1996-05-03
SK56696A3 (en) 1996-10-02
CN1109045C (zh) 2003-05-21
WO1995012609A1 (de) 1995-05-11
HU9601192D0 (en) 1996-06-28
EP0726907B1 (de) 2002-11-27
EP0726907A1 (de) 1996-08-21
AU7810994A (en) 1995-05-23
CA2175670C (en) 2005-08-02
DE59410213D1 (de) 2003-01-09
ZA948667B (en) 1995-07-07
KR960705841A (ko) 1996-11-08
NO317112B1 (no) 2004-08-16
IL111263A (en) 2000-07-16
CZ290186B6 (cs) 2002-06-12
FI116569B (fi) 2005-12-30
NO961816L (no) 1996-05-03
DE4337573C1 (de) 1995-05-18
CN1134157A (zh) 1996-10-23
HU222087B1 (hu) 2003-04-28
RU2148411C1 (ru) 2000-05-10
PL314185A1 (en) 1996-09-02
FI961900A0 (fi) 1996-05-03
ES2182846T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
UA27732C2 (uk) Спосіб приготування стандартизованого концентрату фактору віллебранда людини та концентрат, одержаний цим способом
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
ES2042058T3 (es) Procedimiento para preparar apoliproteinas a partir de fracciones de plasma sanguineo o suero.
DE69002395D1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
DK0429570T3 (da) Osteoinducerende præparater
UA11061A (uk) Спосіб розділеhhя білків крові
NO951761L (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
NO920834L (no) Fremgangsmaate for inaktivering av virus i blod og blodprodukter
ES2057475T3 (es) Procedimiento para la preparacion de concentrado de complejo factor viii-factor de willebrand de la coagulacion sanguinea a partir de plasma total.
ATE297750T1 (de) Verwendung von hsp70 protein
FI961900A (fi) Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä
AU561222B2 (en) Process for the pasteurization of human plasma
ES2173927T3 (es) Procedimiento para la preparacion de un concentrado de inter-alfa-tripsina inhibidor de uso terapeutico, y concentrado obtenido.
ES2053684T3 (es) Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
AR018260A1 (es) Un proceso para preparar una solucion de gammaglobulina que puede ser administrada por via intravenosa, y solucion de gammaglobulina obtenida por dichoproceso
GR3005036T3 (fi)
PT733104E (pt) Purificacao de proteinas dependentes de vitamina k por cromatografia de membrana
EP0456842A4 (en) Medicinal application of m-csf
ATE329602T1 (de) Verfahren zur herstellung von gereinigtem transferrin
ES2117197T3 (es) Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1.
ES2094701A1 (es) Procedimiento para la produccion de antitrombina iii
UA13922A (uk) Спосіб одержаhhя коhтріhсуліhового фактора, який блокує зв'язуваhhя іhсуліhу з його рецептором та має діабетогеhhу дію
RU95108777A (ru) Способ коррекции пресбиопии со смешанным астигматизмом

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116569

Country of ref document: FI